{
  "timestamp": "20250619_122846",
  "evaluation_duration": 38.27422499656677,
  "pipeline_results": {
    "BasicRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "Based on the provided context documents, there is no specific information available regarding the effects of metformin on type 2 diabetes. To provide a comprehensive answer, the following information would be helpful:\n\n1. Mechanism of action of metformin in the body.\n2. Clinical outcomes associated with metformin use in type 2 diabetes patients, such as blood sugar control, weight management, and cardiovascular benefits.\n3. Potential side effects or contraindications of metformin.\n4. Comparison of metformin with other diabetes medications.\n5. Long-term effects of metformin on diabetes progression and complications.\n\nWithout this information, I cannot provide a detailed answer regarding the effects of metformin on type 2 diabetes.",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 3.0322439670562744,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "Based on the provided context documents, there is no specific information available regarding how SGLT2 inhibition affects kidney function. To provide a comprehensive answer, the following information would be helpful:\n\n1. Mechanism of action of SGLT2 inhibitors and their impact on renal glucose reabsorption.\n2. Effects of SGLT2 inhibition on glomerular filtration rate (GFR).\n3. Potential benefits of SGLT2 inhibitors in patients with diabetic kidney disease.\n4. Any adverse effects or considerations regarding kidney function when using SGLT2 inhibitors.\n\nSince the context documents do not contain this information, I cannot provide a detailed answer regarding the effects of SGLT2 inhibition on kidney function.",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 2.812807321548462,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "The context documents provided do not contain any information regarding the mechanism of action of GLP-1 receptor agonists. Therefore, I cannot provide a comprehensive answer based on the given context. \n\nHowever, I can provide a general overview of the mechanism of action of GLP-1 receptor agonists based on my training data:\n\nGLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications used primarily in the treatment of type 2 diabetes. Their mechanism of action includes the following key points:\n\n1. **Increased Insulin Secretion**: GLP-1 receptor agonists stimulate the pancreas to release insulin in response to meals, particularly when blood glucose levels are elevated.\n\n2. **Decreased Glucagon Secretion**: These medications reduce the secretion of glucagon, a hormone that raises blood glucose levels, thereby helping to lower overall blood sugar.\n\n3. **Slowed Gastric Emptying**: GLP-1 receptor agonists slow down the rate at which food leaves the stomach, which helps to reduce postprandial (after meal) blood sugar spikes.\n\n4. **Increased Satiety**: They promote a feeling of fullness, which can help reduce food intake and support weight loss, a beneficial effect for many patients with type 2 diabetes.\n\n5. **Cardiovascular Benefits**: Some GLP-1 receptor agonists have been shown to have cardiovascular benefits, including reducing the risk of major adverse cardiovascular events.\n\nIf you need more specific information or details, please provide additional context or documents.",
        "contexts": [],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 6.604758024215698,
        "success": true,
        "error": null
      }
    ]
  },
  "ragas_results": {
    "BasicRAG": {
      "answer_relevancy": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": 0.43030303030303035,
      "answer_similarity": null,
      "answer_correctness": 0.34769993406414684
    }
  }
}